Steven K Malin, Mary-Margaret E Remchak, Emily M Heiston, Chiara Fabris, Ankit M Shah
{"title":"Pancreatic β-cell Function is Higher in Morning Versus Intermediate Chronotypes With Obesity.","authors":"Steven K Malin, Mary-Margaret E Remchak, Emily M Heiston, Chiara Fabris, Ankit M Shah","doi":"10.1002/osp4.70064","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>People with later chronotypes are at greater T2D risk, yet it is unknown if β-cell function differs among chronotypes. Thus we, assessed β-cell function in morning (MORN) and intermediate (INT) chronotypes with obesity.</p><p><strong>Methods: </strong>Adults (<i>n</i> = 41, 9M, 55 ± 1.7 y, 36.8 ± 1.0 kg/m<sup>2</sup>) were grouped as MORN or INT per the Morningness-Eveningness Questionnaire. Glucose, insulin, C-peptide, GIP, and GLP-1(active) were collected every 30 min during a 120 min 75g-OGTT. Insulin secretion rates (ISR) were calculated (regularized deconvolution) to assess early (total area under the curve; tAUC<sub>0-30min</sub>) and total-phase (tAUC<sub>0-120min</sub>) glucose-stimulated insulin secretion (GSIS:ISR/Glucose). Skeletal muscle (glucose infusion rate/steady-state insulin) insulin sensitivity and hepatic (HOMA-IR) as well as adipose (Adipose-IR) insulin resistance were assessed during a 120 min euglycemic hyperinsulinemic clamp (40mU/m<sup>2</sup>/min, 90 mg/dL). β-cell function (disposition index (DI): GSIS adjusted insulin sensitivity) was determined. Body composition (DXA) and fitness (VO<sub>2</sub>max) were also measured.</p><p><strong>Results: </strong>Age, body composition and VO<sub>2</sub>max were similar between groups, but INT had reduced muscle insulin sensitivity and higher hepatic and adipose IR (<i>p</i> < 0.05). INT had higher C-peptide tAUC<sub>0-30min</sub> (<i>p</i> = 0.04) and lower hepatic DI (tAUC<sub>0-30min</sub> <i>p</i> = 0.05 and tAUC<sub>0-120min</sub> <i>p</i> = 0.07, respectively). Early phase hepatic DI correlated with GLP-1 tAUC<sub>0-30min</sub> (<i>r</i> = 0.35, <i>p</i> < 0.02) and tAUC<sub>0-120min</sub> (<i>r</i> = -0.40, <i>p</i> = 0.04).</p><p><strong>Conclusions: </strong>β-cell function was higher in MORN versus INT chronotypes. Further work is warranted to discern how chronotype impacts insulin secretion.</p><p><strong>Trial registration: </strong>NCT03355469.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":"11 2","pages":"e70064"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11864105/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Science & Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/osp4.70064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: People with later chronotypes are at greater T2D risk, yet it is unknown if β-cell function differs among chronotypes. Thus we, assessed β-cell function in morning (MORN) and intermediate (INT) chronotypes with obesity.
Methods: Adults (n = 41, 9M, 55 ± 1.7 y, 36.8 ± 1.0 kg/m2) were grouped as MORN or INT per the Morningness-Eveningness Questionnaire. Glucose, insulin, C-peptide, GIP, and GLP-1(active) were collected every 30 min during a 120 min 75g-OGTT. Insulin secretion rates (ISR) were calculated (regularized deconvolution) to assess early (total area under the curve; tAUC0-30min) and total-phase (tAUC0-120min) glucose-stimulated insulin secretion (GSIS:ISR/Glucose). Skeletal muscle (glucose infusion rate/steady-state insulin) insulin sensitivity and hepatic (HOMA-IR) as well as adipose (Adipose-IR) insulin resistance were assessed during a 120 min euglycemic hyperinsulinemic clamp (40mU/m2/min, 90 mg/dL). β-cell function (disposition index (DI): GSIS adjusted insulin sensitivity) was determined. Body composition (DXA) and fitness (VO2max) were also measured.
Results: Age, body composition and VO2max were similar between groups, but INT had reduced muscle insulin sensitivity and higher hepatic and adipose IR (p < 0.05). INT had higher C-peptide tAUC0-30min (p = 0.04) and lower hepatic DI (tAUC0-30minp = 0.05 and tAUC0-120minp = 0.07, respectively). Early phase hepatic DI correlated with GLP-1 tAUC0-30min (r = 0.35, p < 0.02) and tAUC0-120min (r = -0.40, p = 0.04).
Conclusions: β-cell function was higher in MORN versus INT chronotypes. Further work is warranted to discern how chronotype impacts insulin secretion.